牛牛AI助理已提取核心訊息
Seth Lederman, the Chief Executive Officer of Tonix Pharmaceuticals Holding Corp. (TNXP), was reported to have engaged in a transaction involving the company's stock on February 27, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and total value of shares, were not disclosed in the announcement. As a result, the number of shares Lederman holds after the action remains unknown.
Seth Lederman, the Chief Executive Officer of Tonix Pharmaceuticals Holding Corp. (TNXP), was reported to have engaged in a transaction involving the company's stock on February 27, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and total value of shares, were not disclosed in the announcement. As a result, the number of shares Lederman holds after the action remains unknown.
據報道，Tonix Pharmicals Holding Corp.（TNXP）首席執行官塞思·萊德曼於2024年2月27日參與了一項涉及該公司股票的交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。因此，萊德曼在行動後持有的股票數量仍然未知。
據報道，Tonix Pharmicals Holding Corp.（TNXP）首席執行官塞思·萊德曼於2024年2月27日參與了一項涉及該公司股票的交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。因此，萊德曼在行動後持有的股票數量仍然未知。
有用
沒用